What are the signs of ototoxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Signs of Ototoxicity

The primary signs of ototoxicity are hearing loss (particularly high-frequency sensorineural hearing loss), tinnitus, dizziness, and vertigo 1.

Auditory Signs

Hearing Loss

  • High-frequency sensorineural hearing loss is the hallmark presentation, typically affecting frequencies between 4,000-8,000 Hz initially before progressing to lower frequencies 1, 2
  • Hearing loss is defined as >15 dB threshold shift at frequencies between 250-16,000 Hz on pure-tone audiometry 1
  • Patients may report difficulty understanding speech, particularly in noisy environments, even before measurable hearing loss appears on standard audiometry 1
  • The loss typically begins in the high frequencies (which are less critical for speech understanding) and can progress downward to affect speech frequencies (2,000 Hz and below), causing more clinically apparent deficits 2

Tinnitus

  • Ringing, buzzing, or other phantom sounds in the ears
  • Can occur with or without measurable hearing loss 1
  • Particularly associated with platinum-based chemotherapy (cisplatin) and moderate-to-high dose head/brain radiotherapy (≥30 Gy) 1

Vestibular Signs

Balance and Vestibular Dysfunction

  • Dizziness - a sensation of lightheadedness or unsteadiness 3, 4, 5
  • Vertigo - a spinning sensation or false sense of movement 3, 4, 5
  • Giddiness and balance disturbances 6

Clinical Grading and Severity Indicators

The Chang grading system provides practical clinical correlation 2:

  • Grade 1a/1b: Measurable hearing loss on audiometry but usually subjectively inapparent to the patient; rarely requires intervention (Grade 1b may occasionally need FM systems)
  • Grade 2a/2b: Clinically significant hearing loss that is subjectively apparent to patients and usually requires intervention (Grade 2a favors FM systems; Grade 2b requires hearing aids)
  • Grade 3: Severe hearing loss absolutely requiring hearing aids; patients often continue to have speech discrimination problems even when aided, particularly when ototoxicity affects the 2 kHz region causing sound distortion 2
  • Grade 4: Profound hearing loss with poor outcomes even with hearing aid amplification 2

Important Clinical Pitfalls

Early ototoxicity may be asymptomatic because initial damage occurs at ultra-high frequencies (>8,000 Hz) that are not routinely tested and are not critical for everyday communication 2. Patients may not notice problems until the damage progresses to speech-relevant frequencies.

Pediatric considerations: Young children may not report symptoms and require objective testing methods. Behavioral changes, speech/language delays, or academic difficulties may be the only presenting signs 1.

Delayed onset: Ototoxicity can develop during treatment, immediately after completion, or even months to years later, particularly with platinum-based chemotherapy 1. This necessitates long-term surveillance rather than single-point assessment.

When to Refer

Immediate referral to an audiologist, auditory clinic, or ENT physician is strongly recommended for 1:

  • Any symptoms suggesting hearing loss (difficulty understanding speech, asking for repetition, turning up volume)
  • Tinnitus
  • Dizziness or vertigo
  • Atypical audiological test results showing loss >15 dB at 1,000-8,000 Hz

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.